Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lamia Remila"'
Autor:
Lamia Remila, Nazende Guenday-Tuereli, Ursula Houngue, Eugenia Belcastro, Christophe Bruckert, Thierry Vandamme, Emre Tuereli, Paul Kerth, Cyril Auger, Valérie Schini-Kerth
Publikováno v:
Journal of Functional Foods, Vol 91, Iss , Pp 105003- (2022)
Omega-3 polyunsaturated fatty acids including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been shown to reduce cardiovascular risk. This study investigated whether nanoencapsulation of EPA:DHA 6:1 is associated with an improved be
Externí odkaz:
https://doaj.org/article/cd178ffc8a5540be88698e8b27db4cf9
Autor:
Ursula Hounguè, Claire Villette, Jean-Marie Tokoudagba, Ahmed B. Chaker, Lamia Remila, Cyril Auger, Dimitri Heintz, Fernand A. Gbaguidi, Valérie B. Schini-Kerth
Publikováno v:
Phytomedicine
Phytomedicine, 2022, 105, pp.154370. ⟨10.1016/j.phymed.2022.154370⟩
Phytomedicine, 2022, 105, pp.154370. ⟨10.1016/j.phymed.2022.154370⟩
International audience; Background: Hypertension is a major cardiovascular risk factor that affects most countries including those of Africa. Although Carissa edulis Vahl, Diodia scandens Sw. and Cleome gynandra L. are traditionally used in Benin as
Autor:
Asad Ur Rehman, Lamia Remila, Valérie B. Schini-Kerth, Sin-Hee Park, Jacky G. Goetz, Eugenia Belcastro, Thierry F. Vandamme, Andrey S. Klymchenko, Nicolas Anton, Olivier Lefebvre, Mayeul Collot, Cyril Auger, Dal Seong Gong
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine
Nanomedicine: Nanotechnology, Biology and Medicine, Elsevier, 2021, 34, ⟨10.1016/j.nano.2021.102379⟩
Nanomedicine: Nanotechnology, Biology and Medicine, 2021, 34, ⟨10.1016/j.nano.2021.102379⟩
Nanomedicine: Nanotechnology, Biology and Medicine, Elsevier, 2021, 34, ⟨10.1016/j.nano.2021.102379⟩
Nanomedicine: Nanotechnology, Biology and Medicine, 2021, 34, ⟨10.1016/j.nano.2021.102379⟩
International audience; Endothelial senescence has been identified as an early event in the development of endothelial dysfunction, a hallmark of cardiovascular disease. This study developed theranostic nanocarriers (NC) decorated with VCAM-1 antibod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea383abb438654d846ed9c61172fe153
Autor:
Faraj Zgheel, Olivier Morel, Valérie B. Schini-Kerth, Cyril Auger, Jean-Philippe Mazzucotelli, Lamia Remila, Stéphanie Perrier, Ursula Houngue
Publikováno v:
European Journal of Pharmacology
European Journal of Pharmacology, 2019, 853, pp.41-48. ⟨10.1016/j.ejphar.2019.03.022⟩
European Journal of Pharmacology, Elsevier, 2019, 853, pp.41-48. ⟨10.1016/j.ejphar.2019.03.022⟩
European Journal of Pharmacology, 2019, 853, pp.41-48. ⟨10.1016/j.ejphar.2019.03.022⟩
European Journal of Pharmacology, Elsevier, 2019, 853, pp.41-48. ⟨10.1016/j.ejphar.2019.03.022⟩
International audience; At arterial sites of endothelial denudation and dysfunction, activated platelets contribute to vascular injury through the release of potent contracting factors such as serotonin (5-HT). This study evaluated whether omega-3 po